GLUT1DS1
9
0
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome
Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome
Diet Treatment Glucose Transporter Type 1 Deficiency (G1D)
Harmonic Ratio in Patients With GLUT1 Deficiency Syndrome
Compatibility of C7 With Ketogenic Diet in Patients Diagnosed With G1D
Ketonemia Through Menstrual Cycle
Treatment Development of Triheptanoin (G1D)
Sodium Lactate Infusion in GLUT1DS Patients
Long-term Treatment With the Ketogenic Diet in Epilepsy